NovoCure Ltd
NVCR· Nasdaq
NVCRNovoCure Ltd
Filed Apr 27, 2017 · 10-Q · 27 days after period end · 0001564590-17-007412
| Metric | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|
| Revenue | $34.88M | $13.05M | $5.21M |
| Net Income | -$18.05M | -$35.44M | -$23.27M |
| EPS Diluted | -$0.21 | -$0.42 | -$1.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NovoCure Ltd · CIK 1645113 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed Apr 27, 2017 · 27 d after period end
